Literature DB >> 31701345

The role of the kidney in acute and chronic heart failure.

Gaetano Ruocco1,2, Alberto Palazzuoli3, Jozine M Ter Maaten4.   

Abstract

Renal dysfunction affects approximately 30 to 50% of heart failure (HF) patients. The unfavourable relationship between heart and kidney dysfunction contributes to worse outcomes through several mechanisms such as inflammation, oxidative stress, impaired hydrosaline homeostasis, and diuretic resistance. Renal dysfunction not only carries important prognostic value both in acute and in chronic HF, but also is a potential precipitating factor after the first diagnosis. Because renal dysfunction encompasses different etiologies, a better understanding of its definition, incidence, and pathophysiology provides additional information. Although old and novel available biomarkers for the detection of renal dysfunction have been recently proposed, there is no general consensus regarding the terminology and definition of renal dysfunction in HF. Due to some specific pathophysiological mechanisms, renal impairment seems to be different on an individual patient level and, recognizing it in acute and chronic settings, could be useful to optimize decongestive treatment. For these reasons, in this review, we aim to describe and evaluate different phenotypes of renal dysfunction in acute and chronic HF and the possible management in these settings. KEY MESSAGES: • Chronic kidney dysfunction and worsening renal function are highly prevalent in acute heart failure and chronic heart failure and associated with poor outcomes. • This association is modified by the context in which it occurs, i.e. worsening renal function in the context of adequate decongestion in acute heart failure, or worsening renal function after initiation of neurohormonal blockers in chronic heart failure. • Future research should be aimed at elucidating the mechanisms involved in these differenct contexts, as well as alternative treatment approaches in the case of true worsening renal function.

Entities:  

Keywords:  Acute heart failure; Chronic heart failure; Outcome; Pathophysiology; Renal dysfunction; Worsening renal function

Mesh:

Substances:

Year:  2020        PMID: 31701345     DOI: 10.1007/s10741-019-09870-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  100 in total

1.  High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.

Authors:  J Thomas Heywood; Gregg C Fonarow; Maria Rosa Costanzo; Vandana S Mathur; John R Wigneswaran; Janet Wynne
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

2.  Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH).

Authors:  Martin R Cowie; Michel Komajda; Tarita Murray-Thomas; Jonathan Underwood; Barry Ticho
Journal:  Eur Heart J       Date:  2006-04-19       Impact factor: 29.983

3.  Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.

Authors:  John E A Blair; Peter S Pang; Robert W Schrier; Marco Metra; Brian Traver; Thomas Cook; Umberto Campia; Andrew Ambrosy; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Marvin A Konstam; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2011-07-23       Impact factor: 29.983

4.  Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.

Authors:  Adriaan A Voors; Mauro Gori; Licette C Y Liu; Brian Claggett; Michael R Zile; Burkert Pieske; John J V McMurray; Milton Packer; Victor Shi; Martin P Lefkowitz; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2015-02-06       Impact factor: 15.534

5.  Diagnostic and prognostic value of cystatin C in acute heart failure.

Authors:  Tobias Breidthardt; Zaid Sabti; Ronny Ziller; Frank Rassouli; Raphael Twerenbold; Nikola Kozhuharov; Etienne Gayat; Samyut Shrestha; Sara Barata; Patrick Badertscher; Jasper Boeddinghaus; Thomas Nestelberger; Christian Mueller
Journal:  Clin Biochem       Date:  2017-07-26       Impact factor: 3.281

Review 6.  Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data.

Authors:  Kevin Damman; W H Wilson Tang; G Michael Felker; Johan Lassus; Faiez Zannad; Henry Krum; John J V McMurray
Journal:  J Am Coll Cardiol       Date:  2013-12-12       Impact factor: 24.094

7.  Worsening renal function is not associated with response to treatment in acute heart failure.

Authors:  Sameer Ather; Chirag Bavishi; Mark D McCauley; Amandeep Dhaliwal; Anita Deswal; Sarah Johnson; Wenyaw Chan; David Aguilar; Allison M Pritchett; Kumudha Ramasubbu; Xander H T Wehrens; Biykem Bozkurt
Journal:  Int J Cardiol       Date:  2012-05-25       Impact factor: 4.164

8.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

Authors:  Kevin Damman; Vincent M van Deursen; Gerjan Navis; Adriaan A Voors; Dirk J van Veldhuisen; Hans L Hillege
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

9.  Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).

Authors:  Kevin Damman; Tiny Jaarsma; Adriaan A Voors; Gerjan Navis; Hans L Hillege; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2009-09       Impact factor: 15.534

10.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

View more
  6 in total

Review 1.  Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2022-05       Impact factor: 4.214

2.  Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge.

Authors:  Toshitaka Okabe; Tadayuki Yakushiji; Takehiko Kido; Taro Kimura; Yu Asukai; Suguru Shimazu; Jumpei Saito; Yuji Oyama; Wataru Igawa; Morio Ono; Seitaro Ebara; Kennosuke Yamashita; Myong Hwa Yamamoto; Kisaki Amemiya; Naoei Isomura; Masahiko Ochiai
Journal:  ESC Heart Fail       Date:  2020-07-09

Review 3.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 4.  Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Authors:  Mouhamed Nashawi; Mahmoud S Ahmed; Toka Amin; Mujahed Abualfoul; Robert Chilton
Journal:  World J Cardiol       Date:  2021-12-26

Review 5.  The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines.

Authors:  Matteo Beltrami; Massimo Milli; Lorenzo Lupo Dei; Alberto Palazzuoli
Journal:  J Clin Med       Date:  2022-04-17       Impact factor: 4.964

6.  Tachycardia and Pre-existing Chronic Kidney Disease Are Predictors of the Worse Clinical Outcomes in Patients Recently Hospitalized With Acute Heart Failure.

Authors:  Leonardo P Suciadi; Kevin Wibawa; Giovanni Jessica; Joshua Henrina; Irvan Cahyadi; Bryany T Santi; Titus K Hariadi; Firman Tedjasukmana; Nathania M Kristanti; Elisa F Pakpahan; Reynold A Manullang; Antono Sutandar
Journal:  Cureus       Date:  2021-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.